Could palliative sedation be seen as unnamed euthanasia?: a survey among healthcare professionals in oncology.
End-of-life
Euthanasia
Legislation
Palliative care
Sedation
Journal
BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685
Informations de publication
Date de publication:
19 Jul 2023
19 Jul 2023
Historique:
received:
19
09
2022
accepted:
03
07
2023
medline:
21
7
2023
pubmed:
20
7
2023
entrez:
19
7
2023
Statut:
epublish
Résumé
In 2016 a French law created a new right for end-of-life patients: deep and continuous sedation maintained until death, with discontinuation of all treatments sustaining life such as artificial nutrition and hydration. It was totally unprecedented that nutrition and hydration were explicitly defined in France as sustaining life treatments, and remains a specificity of this law. End- of-life practices raise ethical and practical issues, especially in Europe actually. We aimed to know how oncology professionals deal with the law, their opinion and experience and their perception. Online mono-centric survey with closed-ended and open-ended questions in a Cancer Comprehensive Centre was elaborated. It was built during workshops of the ethics committee of the Institute, whose president is an oncologist with a doctoral degree in medical ethics. 58 oncologists and 121 nurses-all professionals of oncological departments -, received it, three times, as mail, with an information letter. 63/ 179 professionals answered the questionnaire (35%). Conducting end-of-life discussions and advanced care planning were reported by 46/63 professionals. In the last three months, 18 doctors and 7 nurses faced a request for a deep and continuous sedation maintained until death, in response to physical or existential refractory suffering. Artificial nutrition and even more hydration were not uniformly considered as treatment. Evaluation of the prognosis, crucial to decide a deep and continuous sedation maintained until death, appears to be very difficult and various, between hours and few weeks. Half of respondents were concerned that this practice could lead to or hide euthanasia practices, whereas for the other half, this new law formalised practices necessary for the quality of palliative care at the end-of-life. Most respondents support the implementation of deep and continuous sedation maintained until death in routine end-of-life care. Nevertheless, difficulty to stop hydration, confusion with euthanasia practices, ethical debates it provokes and the risk of misunderstanding within teams and with families are significant. This is certainly shared by other teams. This could lead to a multi-centric survey and if confirmed might be reported to the legislator.
Sections du résumé
BACKGROUND
BACKGROUND
In 2016 a French law created a new right for end-of-life patients: deep and continuous sedation maintained until death, with discontinuation of all treatments sustaining life such as artificial nutrition and hydration. It was totally unprecedented that nutrition and hydration were explicitly defined in France as sustaining life treatments, and remains a specificity of this law. End- of-life practices raise ethical and practical issues, especially in Europe actually. We aimed to know how oncology professionals deal with the law, their opinion and experience and their perception.
METHODS
METHODS
Online mono-centric survey with closed-ended and open-ended questions in a Cancer Comprehensive Centre was elaborated. It was built during workshops of the ethics committee of the Institute, whose president is an oncologist with a doctoral degree in medical ethics. 58 oncologists and 121 nurses-all professionals of oncological departments -, received it, three times, as mail, with an information letter.
RESULTS
RESULTS
63/ 179 professionals answered the questionnaire (35%). Conducting end-of-life discussions and advanced care planning were reported by 46/63 professionals. In the last three months, 18 doctors and 7 nurses faced a request for a deep and continuous sedation maintained until death, in response to physical or existential refractory suffering. Artificial nutrition and even more hydration were not uniformly considered as treatment. Evaluation of the prognosis, crucial to decide a deep and continuous sedation maintained until death, appears to be very difficult and various, between hours and few weeks. Half of respondents were concerned that this practice could lead to or hide euthanasia practices, whereas for the other half, this new law formalised practices necessary for the quality of palliative care at the end-of-life.
CONCLUSION
CONCLUSIONS
Most respondents support the implementation of deep and continuous sedation maintained until death in routine end-of-life care. Nevertheless, difficulty to stop hydration, confusion with euthanasia practices, ethical debates it provokes and the risk of misunderstanding within teams and with families are significant. This is certainly shared by other teams. This could lead to a multi-centric survey and if confirmed might be reported to the legislator.
Identifiants
pubmed: 37468913
doi: 10.1186/s12904-023-01219-z
pii: 10.1186/s12904-023-01219-z
pmc: PMC10354970
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
97Informations de copyright
© 2023. The Author(s).
Références
Appl Nurs Res. 2018 Apr;40:157-161
pubmed: 29579492
Palliat Med. 2009 Jul;23(5):410-7
pubmed: 19304807
J Pain Palliat Care Pharmacother. 2012;26(1):30-9
pubmed: 22448939
J Support Oncol. 2013 Jun;11(2):68-74
pubmed: 23967494
Int J Nurs Stud. 2021 May;117:103859
pubmed: 33545642
BMC Palliat Care. 2020 Jun 19;19(1):85
pubmed: 32560644
BMJ Support Palliat Care. 2013 Dec;3(4):458-9
pubmed: 24950529
Eur J Cancer. 2000 Oct;36(16):2036-43
pubmed: 11044639
J Pain Symptom Manage. 2006 Feb;31(2):122-9
pubmed: 16488345
Palliat Care. 2019 Jan 27;12:1178224218823511
pubmed: 30728718
Intensive Care Med. 1997 Dec;23(12):1264-7
pubmed: 9470083
Ann Palliat Med. 2021 Mar;10(3):3563-3574
pubmed: 32648455
Ann Palliat Med. 2021 Mar;10(3):3554-3562
pubmed: 32787356
J Palliat Care. 2020 Jan;35(1):13-20
pubmed: 30757945
Ann Oncol. 2009 Jul;20(7):1163-9
pubmed: 19542532
J Pain Symptom Manage. 2003 Feb;25(2):103-5
pubmed: 12590025
BMC Palliat Care. 2017 Jan 21;16(1):7
pubmed: 28109272
J Am Med Dir Assoc. 2014 Aug;15(8):570-5
pubmed: 24835856
Annu Rev Psychol. 2001;52:397-422
pubmed: 11148311
Hum Resour Health. 2020 Jun 5;18(1):41
pubmed: 32503559
BMJ Support Palliat Care. 2018 Sep;8(3):307-313
pubmed: 29305500
J Med Ethics. 2019 Feb;45(2):125-130
pubmed: 30352790
BMC Palliat Care. 2021 May 14;20(1):67
pubmed: 33990204
JAMA Intern Med. 2020 Mar 1;180(3):395-401
pubmed: 31904796
J R Soc Med. 2018 Nov;111(11):407-413
pubmed: 30427291
BMC Palliat Care. 2020 Sep 23;19(1):147
pubmed: 32967659
Rev Med Interne. 2017 Dec;38(12):800-805
pubmed: 29102388
Palliat Med. 2009 Oct;23(7):577-9
pubmed: 19858354
BMJ Support Palliat Care. 2013 Jun;3(2):203-6
pubmed: 24644569
Lancet. 2001 Jul 28;358(9278):335-6
pubmed: 11501540
BMC Palliat Care. 2020 Jan 4;19(1):4
pubmed: 31901225
Palliat Med. 2000 Jul;14(4):257-65
pubmed: 10974977
J Clin Oncol. 2007 Aug 1;25(22):3313-20
pubmed: 17664480
Support Care Cancer. 2002 Jul;10(5):385-8
pubmed: 12136221
Palliat Med. 2013 Jun;27(6):553-61
pubmed: 23104513
Palliat Med. 2009 Oct;23(7):581-93
pubmed: 19858355
Yale J Biol Med. 2019 Dec 20;92(4):733-739
pubmed: 31866788
N Engl J Med. 2009 Sep 10;361(11):1119-21
pubmed: 19741238
Braz J Anesthesiol. 2019 Jan - Feb;69(1):72-77
pubmed: 29776669
Cancer. 2004 Sep 1;101(5):1090-8
pubmed: 15329920
BMJ Support Palliat Care. 2012 Mar;2(1):9-11
pubmed: 24653491
GMS J Med Educ. 2016 Feb 15;33(1):Doc11
pubmed: 26958648
J Med Ethics. 2023 Apr;49(4):252-260
pubmed: 36543531
Aten Primaria. 2023 Mar;55(3):102568
pubmed: 36709560
J Pain Symptom Manage. 2011 Jan;41(1):14-24
pubmed: 20832985
J Pain Symptom Manage. 2020 Aug;60(2):355-361
pubmed: 32169541
J Med Ethics. 2012 Nov;38(11):664-8
pubmed: 22811556
J Pain Symptom Manage. 2018 Jun;55(6):1577-1590
pubmed: 29382541
BMC Med Ethics. 2016 Jun 29;17(1):36
pubmed: 27357285
Singapore Med J. 2016 May;57(5):220-7
pubmed: 27211055
Br J Cancer. 2018 Nov;119(10):1288-1296
pubmed: 30353050
J Pain Symptom Manage. 2011 Jul;42(1):32-43
pubmed: 21477981
Wien Klin Wochenschr. 2006 Jun;118(11-12):322-6
pubmed: 16855920
Am J Bioeth. 2019 Mar;19(3):10-20
pubmed: 30896350
Am J Bioeth. 2019 Mar;19(3):21-28
pubmed: 30896352
BMC Palliat Care. 2017 Apr 11;16(1):25
pubmed: 28399846
Pain Med. 2010 Mar;11(3):435-8
pubmed: 20088855
Palliat Med. 1998 Jul;12(4):255-69
pubmed: 9743824
Palliat Med. 2015 Jan;29(1):48-59
pubmed: 25062816
Palliat Med. 2018 Dec;32(11):1639-1640
pubmed: 29532705